Unbound MEDLINE

Effects of Potassium Channel Blockers on Changes in Refractoriness of atrial Cardiomyocytes Induced by Stretch. Experimental biology and medicine (Maywood, N.J.) [Exp Biol Med (Maywood)] Journal article

 
TitleEffects of Potassium Channel Blockers on Changes in Refractoriness of atrial Cardiomyocytes Induced by Stretch.
Author(s)Qi J, Xiao J, Zhang Y, Li J, Liu Y, Li P, Liang L, Jiang B, Wen W, Zhao C, Liang D, Liu Y, Chen Y 
InstitutionTongji University.
SourceExp Biol Med (Maywood) 2009 May 8.
AbstractShortening of the effective refractory period (ERP) is regarded as one of the key mechanisms of atrial fibrillation (AF). Stretch is an important predisposing factor in the pathogenesis of AF. However, effective methods to counteract alteration of ERP induced by stretch still need to be explored. Although potassium channels play important roles in cardiac repolarization and refractoriness, the effects of potassium channel blockers on the alteration of repolarization and refractoriness induced by stretch are still unknown. Action potential duration (APD) and ERP were recorded using the standard intracellular microelectrode technique in the left atrial appendage cardiomyocytes of guinea-pigs. Stretch accelerated repolarization of atrial cardiomyocytes and also shortened the ERP (P<0.05). Dofetilide, a rapid delayed rectifying potassium ion channel (IKr) blocker; 4-AP, a transient outward potassium ion channel (Ito) blocker; and BaCl2, an inward rectifying potassium ion channel (IK1) blocker could counteract the shortening of APD and ERP (P<0.01). Glibenclamide, an ATP sensitive potassium ion channel (IKATP) blocker; 293-B, a slow delayed rectifying potassium channel (IKs) blocker; and DPO-1, an ultra-rapid delayed rectifying potassium ion channel (IKur) blocker all had no effect on APD and ERP (P>0.05). Stretch could accelerate repolarization of atrial cardiomyocytes and shorten their ERP, and the Ito, IKr and IK1 blockers could counteract the effects of stretch.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19429854
  
Advertise on this site.